# Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML

> **NCT05477589** · PHASE3 · RECRUITING · sponsor: **Vastra Gotaland Region** · enrollment: 170 (estimated)

## Conditions studied

- Acute Myeloid Leukemia (AML) in Remission
- Stem Cell Transplantation

## Interventions

- **DRUG:** busulfan, cyclophosphamide and melphalan, BuCyMel
- **DRUG:** clofarabine, fludarabine and busulfan, CloFluBu

## Key facts

- **NCT ID:** NCT05477589
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-07
- **Primary completion:** 2029-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2024-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05477589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05477589, "Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05477589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*